| Literature DB >> 20534623 |
E Van Cutsem1, M Dicato, N Arber, J Berlin, A Cervantes, F Ciardiello, A De Gramont, E Diaz-Rubio, M Ducreux, R Geva, B Glimelius, R Glynne Jones, A Grothey, T Gruenberger, D Haller, K Haustermans, R Labianca, H J Lenz, B Minsky, B Nordlinger, A Ohtsu, N Pavlidis, P Rougier, W Schmiegel, C Van de Velde, H J Schmoll, A Sobrero, J Tabernero.
Abstract
The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20534623 DOI： 10.1093/annonc/mdq273
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976